$OKLO

DeWitte Jacob sold $127K of OKLO (indirect holdings)

DeWitte Jacob (Co-Founder, CEO) sold 1,800 indirectly-held shares of Oklo Inc. (OKLO) at $70.45 ($0.13M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Jun 2, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

This disclosure provides incremental sentiment information but no new operational or financial catalyst for Oklo.

02

Market read

Traders may briefly reassess sentiment around OKLO due to insider selling, but 10b5-1 reduces the likelihood of a sustained repricing.

03

What to watch

The filing notes indirect ownership and post-sale holdings; traders may need to compare prior Form 4 patterns to judge whether selling is routine or increasing.

Relevance 6/10Novelty 6/10Timing: Filed after-hours/next-day disclosure window (SEC Form 4 filed 2026-06-02 for 2026-06-01 sale).

Background

SEC Form 4 discloses insider transactions by officers/directors/10% owners; 10b5-1 plans are pre-arranged to limit trading-timing discretion.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder/CEO DeWitte Jacob sold 1,800 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be small and fade unless accompanied by other catalysts.

Evidence & confidence

The filing is a routine insider disposition with a stated pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity rather than a sector/regulatory/financing catalyst.

None.

None.

Counterpoint

10b5-1 sales often reflect planned liquidity rather than negative fundamentals; the market may ignore it unless volume/pace accelerates.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale by CEO/co-founder DeWitte Jacob.

  • DeWitte Jacob

    Co-Founder, CEO; sold 1,800 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.